Skip to main content
Fig. 6 | Nutrition & Metabolism

Fig. 6

From: Myricetin ameliorates atherosclerosis in the low-density-lipoprotein receptor knockout mice by suppression of cholesterol accumulation in macrophage foam cells

Fig. 6

The Mechanisms of reduced lipid accumulation in myricetin treated macrophages. mRNA (a) and protein (b) expression of CD36, scavenger receptor-A (SR-A), scavenger receptor- BI (SR-BI) and ATP-binding cassette transporter A1 (ABCA1) in macrophages stimulated with ox-LDL. Values are expressed as mean ± SD. *P < 0.05, for Myricetin vs. Vehicle

Back to article page

Nutrition & Metabolism

ISSN: 1743-7075

Contact us